This company has a good potential , however I am not convinced they understand what exactly their drug is doing , drugs acting on Fe pathways are used in Malaria, they are in effect antibiotics , is it not true that the antihelminth drug that is the grandfather of the Pranas pipeline an antibiotic also? The company is seriously undercapitalised and their chief scientists dont understand how their drug really works, a dangerous combination for current investors - logic says expect more downside short to medium term .
tomorrows news today, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.288K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 97593686 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31319254 | 17 |
View Market Depth
| Last trade - 09.59am 26/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |